Title |
Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
|
---|---|
Published in |
Frontiers in immunology, March 2018
|
DOI | 10.3389/fimmu.2018.00609 |
Pubmed ID | |
Authors |
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm |
Abstract |
Testing for liver-related autoantibodies should be included in the workup of patients with hepatitis or cholestasis of unknown origin. Although most of these autoantibodies are not disease specific, their determination is a prerequisite to diagnose autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC), and they are components of the diagnostic scoring system in these diseases. In primary sclerosing cholangitis (PSC), on the other hand, autoantibodies are frequently present but play a minor role in establishing the diagnosis. In PSC, however, data on antibodies suggest a link between disease pathogenesis and the intestinal microbiota. This review will focus on practical aspects of antibody testing in the three major autoimmune liver diseases AIH, PBC, and PSC. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Venezuela, Bolivarian Republic of | 1 | 17% |
Canada | 1 | 17% |
Unknown | 4 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 138 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 18 | 13% |
Student > Ph. D. Student | 13 | 9% |
Researcher | 11 | 8% |
Other | 11 | 8% |
Student > Master | 10 | 7% |
Other | 18 | 13% |
Unknown | 57 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 40 | 29% |
Biochemistry, Genetics and Molecular Biology | 10 | 7% |
Immunology and Microbiology | 10 | 7% |
Agricultural and Biological Sciences | 6 | 4% |
Unspecified | 4 | 3% |
Other | 9 | 7% |
Unknown | 59 | 43% |